Where is the live CopyMark page for USPTO serial 76354586?

The live record is at https://getcopymark.com/trademark/76354586. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns EMD LEXIGEN?

According to the public USPTO record for serial number 76354586, the listed owner(s) include: Merck KGaA.

What is USPTO serial number 76354586?

Serial number 76354586 is the USPTO application identifier for the mark EMD LEXIGEN. It is used to track examination, publication, and registration of this trademark.

Which trademark classes cover EMD LEXIGEN?

The public record lists International Classes: 005, 042. Each class corresponds to categories of goods or services identified in the application or registration.

4.9/5

USPTO serial 76354586

EMD LEXIGEN

Q: What is the current status of EMD LEXIGEN?

EMD LEXIGEN (76354586) currently shows USPTO status code 603 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Reviewed by CopyMark Law Group

Status 603

Filing date: Dec 27, 2001
Status date: Sep 11, 2006
Registration date: —
Examiner: WELLS, KELLEY L
Law office: TMEG LAW OFFICE 105 - EXAMINING ATTORNEY ASSIGNED

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with EMD LEXIGEN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

Merck KGaA
D-64293 Darmstadt, DE
Other trademarks owned by Merck KGaA

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

H. John Campaign

H JOHN CAMPAIGN GRAHAM, CAMPAIGN PC36 W 44TH ST STE 1300NEW YORK, NY 10036-8178UNITED STATES

Goods and services

Class	Description	Status	First use
005	Pharmaceutical and biopharmaceutical products for the treatment of cancer, MDS, genetic disorders and immunological disorders; novel protein drugs for use in the area of oncology, immune therapies and for the treatment of metabolic disorders	ACTIVE	—
042	Scientific research and development in the area of pharmacy, medicine, biology and genetics, developing treatments for serious and life-threatening diseases as well as broad technology platforms that will lead to new therapies	ACTIVE	—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Sep 15, 2006	MAB3	ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL	—
Sep 11, 2006	ABN3	ABANDONMENT - AFTER EX PARTE APPEAL	—
Sep 11, 2006	EXPT	EXPARTE APPEAL TERMINATED	—
Jun 13, 2006	EXPA	EX PARTE APPEAL-REFUSAL AFFIRMED	—
Dec 6, 2005	CNES	EXAMINERS STATEMENT MAILED	—
Dec 4, 2005	CNES	EXAMINERS STATEMENT - COMPLETED	—
Oct 5, 2005	JURT	JURISDICTION RESTORED TO EXAMINING ATTORNEY	—
May 19, 2005	RECD	ACTION DENYING REQ FOR RECON MAILED	—
May 19, 2005	CNCF	ACTION CONTINUING FINAL - COMPLETED	—
Mar 2, 2005	EXPI	EX PARTE APPEAL-INSTITUTED	—
Mar 2, 2005	JURT	JURISDICTION RESTORED TO EXAMINING ATTORNEY	—
Mar 1, 2005	EXAF	EXPARTE APPEAL RECEIVED AT TTAB	—
Feb 18, 2005	MAIL	PAPER RECEIVED	—
Aug 16, 2004	CNFR	FINAL REFUSAL MAILED	A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 16, 2004	GNFR	FINAL REFUSAL E-MAILED	A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 26, 2004	CFIT	CASE FILE IN TICRS	—
Feb 26, 2004	CFIT	CASE FILE IN TICRS	—
Feb 19, 2004	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Feb 19, 2004	MAIL	PAPER RECEIVED	—
Aug 15, 2003	CNRT	NON-FINAL ACTION MAILED	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 28, 2003	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Feb 28, 2003	MAIL	PAPER RECEIVED	—
Nov 25, 2002	CNSL	LETTER OF SUSPENSION MAILED	—
Nov 20, 2002	CNEA	EXAMINERS AMENDMENT MAILED	—
Nov 7, 2002	MAIL	PAPER RECEIVED	—
Oct 28, 2002	1.BD	Sec. 1(B) CLAIM DELETED	—
Oct 28, 2002	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Oct 28, 2002	MAIL	PAPER RECEIVED	—
Apr 24, 2002	CNRT	NON-FINAL ACTION MAILED	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 10, 2002	DOCK	ASSIGNED TO EXAMINER	—
Mar 20, 2002	DOCK	ASSIGNED TO EXAMINER	—